Rexulti 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F8Y7H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,381
Award facts
- Contract value 100% obligated
- $11,381.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,381.23 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count package) on December 10, 2025, with completion scheduled for December 11, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part of its extensive portfolio of pharmaceutical product deliveries to the Defense Health Agency and other government healthcare systems. The company's federal contract awards consistently demonstrate capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains through competitively awarded delivery orders. This specific award for Rexulti, an antipsychotic medication, exemplifies the company's role in supporting military and federal healthcare supply chains with diverse pharmaceutical products ranging from specialty medications to common therapeutic agents.
Quick answers
Who was awarded contract SPE2DR26F8Y7H?
SPE2DR26F8Y7H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F8Y7H worth?
The government has obligated $11,381 on SPE2DR26F8Y7H.
Is contract SPE2DR26F8Y7H an order under another contract?
Yes. SPE2DR26F8Y7H is a delivery order under SPE2DR25D1107, an indefinite delivery contract.
Was contract SPE2DR26F8Y7H competed?
The extent of competition for SPE2DR26F8Y7H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award